Mon, Nov 18, 2024
Volume 11, Issue 2 (Spring 2021)
PTJ 2021, 11(2): 75-84 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Motaqi M, Hatef B, Askari Ashtiani A, Ghanjal A. Neuromuscular Problems in the Patients With COVID-19: A Review Study. PTJ 2021; 11 (2) :75-84
URL: http://ptj.uswr.ac.ir/article-1-485-en.html
URL: http://ptj.uswr.ac.ir/article-1-485-en.html
1- Physiotherapy Research Center, School of Rehabilitation, Shahid Beheshti University of Medical Sciences,Tehran, Iran.
2- Neuroscience Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
3- Health Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.
4- Health Management Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
2- Neuroscience Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
3- Health Promotion Research Center, Zahedan University of Medical Sciences, Zahedan, Iran.
4- Health Management Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran.
Abstract: (2561 Views)
Purpose: SARS-CoV-2 is a member of the betacoronavirus genus that primarily targets the human respiratory system and causes pneumonia-like symptoms. This article aims to review neuromuscular problems in patients with COVID-19 based on the available evidence and possible consequences.
Methods: This narrative review study gathered the related and newest studies published (without time limitation) about the neurological impairment of the coronavirus.
Results: The studies showed that the patients with COVID-19 show a variety of respiratory symptoms and neuromuscular and neurological symptoms. The neurological symptoms associated with the underlying disease include headache, dizziness, disturbance of consciousness, ataxia, manifestations of epilepsy, stroke, peripheral nerve injury (like hypoadomia, hyposemia, neuralgia). The findings of this review study also reveal that there are a variety of neuromuscular symptoms in the affected patients. Besides, some specific changes in these symptoms have occurred since the emergence of this epidemic.
Conclusion: Neurologists should pay more attention to the possible signs of direct and indirect involvement of the nervous system and its lasting effects, which might have been ignored in the acute phase of the disease.
Methods: This narrative review study gathered the related and newest studies published (without time limitation) about the neurological impairment of the coronavirus.
Results: The studies showed that the patients with COVID-19 show a variety of respiratory symptoms and neuromuscular and neurological symptoms. The neurological symptoms associated with the underlying disease include headache, dizziness, disturbance of consciousness, ataxia, manifestations of epilepsy, stroke, peripheral nerve injury (like hypoadomia, hyposemia, neuralgia). The findings of this review study also reveal that there are a variety of neuromuscular symptoms in the affected patients. Besides, some specific changes in these symptoms have occurred since the emergence of this epidemic.
Conclusion: Neurologists should pay more attention to the possible signs of direct and indirect involvement of the nervous system and its lasting effects, which might have been ignored in the acute phase of the disease.
Type of Study: Applicable |
Subject:
General
Received: 2020/11/8 | Accepted: 2021/01/12 | Published: 2021/04/1
Received: 2020/11/8 | Accepted: 2021/01/12 | Published: 2021/04/1
Send email to the article author
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC-By-NC), which permits use, distribution, and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Contact Information
